Towards biologically conformal radiation therapy (BCRT): Selective IMRT dose escalation under the guidance of spatial biology distribution

Medical Physics

Volumn 32, Issue 6, 2005, Pages 1473-1484

  Yang, Yong ^a   Xing, Lei ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biological model; IMRT; Inverse planning; NTCP; TCP

Indexed keywords

BIOLOGY; TRANSMISSION CONTROL PROTOCOL; TUMORS;

BIOLOGICAL MODELING; IMRT; INTENSITY-MODULATED RADIATION THERAPY; INVERSE PLANNING; NONUNIFORM DOSE DISTRIBUTION; NORMAL TISSUE COMPLICATION PROBABILITIES; NTCP; SIMULTANEOUS INTEGRATED BOOSTS;

RADIOTHERAPY;

BIOLOGICAL MODEL; CANCER CONTROL; CLONOGENESIS; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; INTENSITY MODULATED RADIATION THERAPY; MATHEMATICAL ANALYSIS; PRESCRIPTION; PRIORITY JOURNAL; RADIOSENSITIVITY;

EID: 21144453545     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1924312     Document Type: Conference Paper

References (57)

1. S. Webb, Intensity-Modulated Radiation Therapy (Institute of Physics, Bristol, 2001), Vol. XV.
2. C. C. Ling, C. Burman, C. S. Chui, G. J. Kutcher, S. A. Leibel, T. LoSasso, R. Mohan, T. Bortfeld, L. Reinstein, S. Spirou, X. H. Wang, Q. Wu, M. Zelefsky, and Z. Fuks, "Conformal radiation treatment of prostate cancer using inversely-planned intensity-modulated photon beams produced with dynamic multileaf collimation," Int. J. Radiat. Oncol., Biol., Phys. 35, 721-730 (1996).
3. S. Y. Woo, W. H. Grant 3rd, D. Bellezza, R. Grossman, P. Gildenberg, L. S. Carpentar, M. Carol, and E. B. Butler, "A comparison of intensity modulated conformal therapy with a conventional external beam stereotactic radiosurgery system for the treatment of single and multiple intracranial lesions," Int. J. Radiat. Oncol., Biol., Phys. 35, 593-597 (1996).
4. N. Lee, P. Xia, J. M. Quivey, K. Sultanem, I. Poon, C. Akazawa, P. Akazawa, V. Weinberg, and K. K. Fu, "Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: An update of the UCSF experience," Int. J. Radiat. Oncol., Biol., Phys. 53, 12-22 (2002).
5. Q. T. Le, L. Xing, and A. L. Boyer, "Head and Neck IMRT," in 3D Conformal Radiation Therapy & Intensity Modulated Radiation Therapy in the Next Millennium, edited by J. G. Purdy and J. Palta (Medical Physics Publishing, Madison, WI, 1999), pp. 190-195.
6. E. Huang, B. S. Teh, D. R. Strother, Q. G. Davis, J. K. Chiu, H. H. Lu, L. S. Carpenter, W. Y. Mai, M. M. Chintagumpala, M. South, W. H. Grant 3rd, E. B. Butler, and S. Y. Woo, "Intensity-modulated radiation therapy for pediatric medulloblastoma: Early report on the reduction of ototoxicity," Int. J. Radiat. Oncol., Biol. Phys. 52, 599-605 (2002).
7. J. G. Rosenman, J. S. Halle, M. A. Socinski, K. Deschesne, D. T. Moore, H. Johnson, R. Fraser, and D. E. Morris, "High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial," Int. J. Radiat. Oncol., Biol., Phys. 54, 348-356 (2002).
8. A. J. Mundt, A. E. Lujan, J. Rotmensch, S. E. Waggoner, S. D. Yamada, G. Fleming, and J. C. Roeske, "Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies," Int. J. Radiat. Oncol., Biol., Phys. 52, 1330-1337 (2002).
9. M. J. Krasin, B. T. Crawford, Y. Zhu, E. S. Evans, M. R. Sontag, L. E. Kun, and T. E. Merchant, "Intensity-modulated radiation therapy for children with intraocular retinoblastoma: Potential sparing of the bony orbit," Clin. Oncol. (R Coll. Radiol) 16, 215-222 (2004).
10. J. Meyer, M. H. Phillips, P. S. Cho, I. Kalet, and J. N. Doctor, "Application of influence diagrams to prostate intensity-modulated radiation therapy plan selection," Phys. Med. Biol. 49, 1637-1653 (2004).
11. A. Eisbruch, "Intensity-modulated radiotherapy of head-and-neck cancer: Encouraging early results," Int. J. Radiat. Oncol., Biol., Phys. 53, 1-3 (2002).
12. M. J. Zelefsky, Z. Fuks, M. Hunt, Y. Yamada, C. Marion, C. C. Ling, H. Amols, E. S. Venkatraman, and S. A. Leibel, "High-dose intensity modulated radiation therapy for prostate cancer: Early toxicity and biochemical outcome in 772 patients," Int. J. Radiat. Oncol., Biol., Phys. 53, 1111-1116 (2002).
13. S. M. Zhou, L. B. Mark's, G. S. Tracton, G. S. Sibley, K. L. Light, P. D. Maguire, and M. S. Anscher "A new three-dimensional dose distribution reduction scheme for tubular organs." Med. Phys. 27, 1727-1731 (2000).
14. C. C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, and J. Koutcher, "Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality," Int. J. Radiat. Oncol., Biol., Phys. 47, 551-560 (2000).
15. A. Brahme, "Individualizing cancer treatment: Biological optimization models in treatment planning and delivery," Int. J. Radiat. Oncol., Biol., Phys. 49, 327-337 (2001).
16. L. Xing, C. Cotrutz, S. Hunjan, A. L. Boyer, E. Adalsteinsson, and D. Spielman, "Inverse planning for functional image-guided intensity-modulated radiation therapy," Phys. Med. Biol. 47, 3567-3578 (2002).
17. K. S. Chao, S. Mutic, R. L. Gerber, C. A. Perez, and J. A. Purdy, "A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy," Int. J. Radiat. Oncol., Biol., Phys. 49, 1171-1182 (2001).
18. R. Macklis, M. Weinhous, and G. Harnisch, "Intensity-modulated radiotherapy: Rethinking basic treatment planning paradigms," Int. J. Radiat. Oncol., Biol., Phys. 48, 317-318 (2000).
19. M. Alber, F. Paulsen, S. M. Eschmann, and H. J. Machulla, "On biologically conformal boost dose optimization," Phys. Med. Biol. 48, N31-35 (2003).
20. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, "Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose," Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002).
21. S. R. Cherry, "In vivo molecular and genomic imaging: New challenges for imaging physics," Phys. Med. Biol. 49, R13-48 (2004).
22. J. Kurhanewicz, M. G. Swanson, S. J. Nelson, and D. B. Vigneron, "Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer," J. Magn. Reson Imaging 16, 451-463 (2002).
23. C. H. Contag and B. D. Ross, "It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology," J. Magn. Reson Imaging 16, 378-387 (2002).
24. S. J. DiBiase, K. Hosseinzadeh, R. P. Gullapalli, S. C. Jacobs, M. J. Naslund, G. N. Sklar, R. B. Alexander, and C. Yu, "Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer," Int. J. Radiat. Oncol., Biol., Phys. 52, 429-438 (2002).
25. J. G. Tjuvajev et al., "Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine," J. Nucl. Med. 35, 1407-1417 (1994).
26. A. F. Shields, J. R. Grierson, B. M. Dohmen, H. J. Machulla, J. C. Stayanoff, J. M. Lawhorn-Crews, J. E. Obradovich, O. Muzik, and T. J. Mangner, "Imaging proliferation in vivo with [F-18] FLT and positron emission tomography," Nat. Med. 4, 1334-1336 (1998).
27. J. S. Rasey, W. J. Koh, M. L. Evans, L. M. Peterson, T. K. Lewellen, M. M. Graham, and K. A. Krohn, "Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients," Int. J. Radiat. Oncol., Biol., Phys. 36, 417-428 (1996).
28. W. J. Koh et al., "Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography," Int. J. Radiat. Oncol., Biol., Phys. 33, 391-398 (1995).
29. B. L. Miller, L. Chang, R. Booth, T. Ernst, M. Cornford, D. Nikas, D. McBride, and D. J. Jenden, "In vivo 1H MRS choline: Correlation with in vitro chemistry/histology," Life Sci. 58, 1929-1935 (1996).
30. R. K. Gupta, T. F. Cloughesy, U. Sinha, J. Garakian, J. Lazareff, G. Rubino, L. Rubino, D. P. Becker, H. V. Vinters, and J. R. Alger, "Relationships between holine magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma," J. Neuro-Oncol. 50, 215-226 (2000).
31. R. J. Hamilton, M. J. Blend, C. A. Pelizzari, B. D. Milliken, and S. Vijayakumar, "Using vascular structure for CT-SPECT registration in the pelvis," J. Nucl. Med. 40, 347-351 (1999).
32. A. F. Shields, D. A. Mankoff, J. M. Link, M. M. Graham, J. F. Eary, S. M. Kozawa, M. Zheng, B. Lewellen, T. K. Lewellen, J. R. Grierson, and K. A. Krohn, "Carbon-11-thymidine and FDG to measure therapy response," J. Nucl. Med. 39, 1757-1762 (1998).
33. L. B. Marks, G. W. Sherouse, M. T. Munley, G. C. Bentel, D. P. Spencer, and C. Scarfone, "Incorporation of functional status into dose-volume analysis," Med. Phys. 26, 196-199 (1999).
34. T. E. Schultheiss, G. K. Zagars, and L. J. Peters. "An explanatory hypothesis for early- and late-effect parameter values in the LQ model," Radiother. Oncol. 9, 241-248 (1987).
35. J. F. Fowler, "The linear-quadratic formula and progress in fractionated radiotherapy," Br. J. Radiol. 62, 679-694 (1989).
36. S. Webb and A. E. Nahum, "A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density," Phys. Med. Biol. 38, 653-666 (1993).
37. S. Webb, P. M. Evans, W. Swindell, and D. J. O., "A proof that uniform dose gives the greatest TCP for fixed integral dose in the planning target volume," Phys. Med. Biol. 39, 2091-2098 (1994).
38. A. Brahme and A. K. Agren, "Optimal dose distribution for eradication of heterogeneous tumours," Acta Oncol. 26, 377-385 (1987).
39. N. A. Stavreva, P. V. Stavrev, and W. H. Round, "A mathematical approach to optimizing the radiation dose distribution in heterogeneous tumours," Acta Oncol. 35, 727-732 (1996).
40. M. A. Ebert and P. W. Hoban, "Some characteristics of tumour control probability for heterogeneous tumours," Phys. Med. Biol. 41, 2125-2133 (1996).
41. D. Levin-Plotnik and R. J. Hamilton, "Optimization of tumour control probability for heterogeneous tumours in fractionated radiotherapy treatment protocols," Phys. Med. Biol. 49, 407-424 (2004).
42. T. E. Schultheiss, C. G. Orton, and R. A. Peck, "Models in radiotherapy: Volume effects," Med. Phys. 10, 410-415 (1983).
43. J. T. Lyman and A. B. Wolbarst, "Optimization of radiation therapy. III. A method of assessing complication probabilities from dose-volume histograms," Int. J. Radiat. Oncol., Biol., Phys. 13, 103-109 (1987).
44. G. J. Kutcher and C. Burman, "Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method," Int. J. Radiat. Oncol., Biol., Phys. 16, 1623-1630 (1989).
45. R. Mohan, G. S. Mageras, B. Baldwin, L. J. Brewster, G. J. Kutcher, S. Leibel, C. M. Burman, C. C. Ling, and Z. Fuks, "Clinically relevant optimization of 3-D conformal treatments," Med. Phys. 19, 933-944 (1992).
46. J. O. Deasy, K. S. Chao, and J. Markman, "Uncertainties in model-based outcome predictions for treatment planning," Int. J. Radiat. Oncol., Biol., Phys. 51, 1389-1399 (2001).
47. M. K. Martel, W. M. Sahijdak, R. K. Ten Haken, M. L. Kessler, and A. T. Turrisi, "Fraction size and dose parameters related to the incidence of pericardial effusions," Int. J. Radiat. Oncol, Biol., Phys. 40, 155-161 (1998).
48. L. Jones and P. Hoban, "A comparison of physically and radiobiologically based optimization for IMRT," Med. Phys. 29, 1447-1455 (2002).
49. Y. Yang and L. Xing, "Clinical knowledge-based inverse treatment planning," Phys. Med. Biol. 49, 5101-5117 (2004).
50. L. Xing and G. T. Y. Chen, "Iterative algorithms for inverse treatment planning," Phys. Med. Biol. 41, 2107-2123 (1996).
51. L. Xing, R. J. Hamilton, D. Speibring, C. A. Pelizzari, G. T. Chen, and A. L. Boyer, "Fast iterative algorithms for three-dimensional inverse treatment planning," Med. Phys. 25, 1845-1849 (1998).
52. Y. Lu, D. R. Speibring, and G. T. Chen, "Functional dose-volume histograms for functionally heterogeneous normal organs," Phys. Med. Biol. 42, 345-356 (1997).
53. C. Burman, G. J. Kutcher, B. Emami, and M. Goitein, "Fitting of normal tissue tolerance data to an analytic function," Int. J. Radiat. Oncol., Biol., Phys. 21. 123-135 (1991).
54. C. R. King, T. A. DiPetrillo, and D. E. Wazer, "Optimal radiotherapy for prostate cancer: Predictions for conventional external beam, IMRT, and brachytherapy from radiobiologic models," Int. J. Radiat. Oncol., Biol., Phys. 46, 165-172 (2000).
55. A. E. Nahum, B. Movsas, E. M. Horwitz, C. C. Stobbe, and J. D. Chapman, "Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the alpha/beta ratio," Int. J. Radiat. Oncol., Biol., Phys. 57, 391-401 (2003).
56. S. L. Scott, P. H. Gumerlock, L. Beckett, Y. Li, and Z. Goldberg, "Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation," Int. J. Radiat. Oncol., Biol., Phys. 59, 219-227 (2004).
57. R. F. Kallman and M. J. Done, "Tumor oxygenation and reoxygenation during radiation therapy: Their importance in predicting tumor response," Int. J. Radiat. Oncol., Biol., Phys. 12, 681-685 (1986).